Tuesday 16 April 2024
Internal Reference Number: FOI_6520
Date Request Received: 15/03/2022 00:00:00
Date Request Replied To: 23/03/2022 00:00:00
This response was sent via: By Email
Request Summary: Prostate Cancer
Request Category: Companies
| Question Number 1: Please provide the total number of patients treated in the last 3 months with any systemic anti-cancer treatment for: • Prostate cancer (any stage) • Metastatic prostate cancer | |
| Answer To Question 1: 72 patients with prostate cancer (any stage) were treated in the last 3 months with sytemic anti-cancer treatments. Of these patients, 69 were metastatic. | |
| Question Number 2: How many patients were treated for prostate cancer (any stage) in the past 3 months with: • Androgen Deprivation Therapy (ADT) standalone • Abiraterone (Zytiga) in combination with any ADT • Abiraterone (Zytiga) - no ADT • Enzalutamide (Xtandi) in combination with any ADT • Enzalutamide (Xtandi) - no ADT • Apalutamide (Erleada) in combination with any ADT • Darolutamide (Nubeqa) in combination with any ADT • Cabazitaxel (Jevtana) • Docetaxel in combination with any ADT • Docetaxel – no ADT • Degarelix (Firmagon) • Olaparib (Lynparza) | |
| Answer To Question 2: As follows: Abiraterone - 21 Enzalutamide - 44 Apalutamide - 0 Docetaxel - 0 Cabazitaxel - 0 Olaparib - 0 We are unable to give figures in relation to Androgen Deprivation Therapy, as patients are given this treatment from stock, and most patients are given this treatment via their GP. You will need to go directly to GPs in order to request this information. | |
| Question Number 3: How many metastatic prostate cancer patients were treated in the past 3 months with: • Androgen Deprivation Therapy (ADT) standalone • Apalutamide (Erleada) in combination with any ADT • Docetaxel in combination with any ADT • Docetaxel – no ADT | |
| Answer To Question 3: As per question 2, we are unable to provide information related to ADT as this treatment is issued from stock and through GPs, as such we cannot provide information relating to this subject. As mentioned previously, you would need to contact the provider directly in order to request this information. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
